Zentalis Pharmaceuticals Current Assets

Zentalis Pharmaceuticals (ZNTL) currently reports a current assets of $180M as of June 2026. That compares with $310M in the prior-year period — down 41.8% year over year. Use the charts on this page to explore Zentalis Pharmaceuticals's current assets history and peer comparisons.

Zentalis Pharmaceuticals's current assets decreased from $310M to $180M — a 41.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zentalis Pharmaceuticals reported $180M in current assets as of June 2026. That compares with $310M in the prior-year period — down 41.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zentalis Pharmaceuticals, and consider following ZNTL for alerts when major investors trade the stock.

Zentalis Pharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $180M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZNTL with unrelated industries.